Insider Transactions in Q1 2024 at Kinnate Biopharma Inc. (KNTE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Richard Thomas Williams CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-0.82%
|
$1,116
$2.59 P/Share
|
|
Mar 01
2024
|
Mark A Meltz COO GENERAL COUNSEL SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-1.98%
|
$1,116
$2.59 P/Share
|
|
Mar 01
2024
|
Neha Krishnamohan CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-2.3%
|
$3,012
$2.59 P/Share
|